Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Although mortality rates from pneumonia and sepsis are decreasing in many parts of the world, the incidence of these conditions continues to rise, likely due to an increasingly aging population. Case reports and observational studies indicate a strong association between vitamin C status and infectious conditions, with vitamin C deficiency predisposing individuals to infections, and conversely, infections precipitating a diminished vitamin C status. The requirements for vitamin C increase with the severity of the infectious condition, with gram amounts required to normalize the vitamin C status of critically ill patients. Over the past few years, there has been renewed interest in the role that vitamin C may play in severe infectious conditions. Vitamin C has a plethora of physiologic effects, primarily due to its activity as a cofactor for a growing group of biosynthetic and regulatory enzymes, with the potential to regulate thousands of genes and cell signaling pathways. Small interventional studies have indicated that administration of gram doses of vitamin C to patients with pneumonia and sepsis improves organ function and potentially decreases mortality, although this remains to be confirmed in larger trials. The long-term quality of life outcomes of these patients also remains to be determined.

Vitamin C --- Therapeutic use.

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Vitamin C holds a unique place in scientific and cultural history. In this book, a group of leading scientific research explore the myriad ways Vitamin C is employed during normal physiological function. This book also provides updates on recent uses ofVitamin C in cancer treatment through high dose intravenous therapies, the ways Vitamin C reduces or prevents sepsis and in the treatment of infectious disease, and the ways Vitamin C improves succesful stem cell transplantation, as well as other health implications. Key selling features: Reviews the history and recent research on the benefits and uses of Vitamin C Focuses special attention on the ways Vitamin C can be used in the treatment of cancers Discusses how Vitamin C is employed against infectious disease Includes chapters from a team of leading international scholars

Vitamin C --- Ascorbic Acid. --- Ascorbic acid --- Vitamin C. --- Therapeutic use. --- therapeutic use. --- Ascorbic Acid, Monosodium Salt --- Ferrous Ascorbate --- Hybrin --- L-Ascorbic Acid --- Magnesium Ascorbate --- Magnesium Ascorbicum --- Magnesium di-L-Ascorbate --- Magnorbin --- Sodium Ascorbate --- Acid, Ascorbic --- Acid, L-Ascorbic --- Ascorbate, Ferrous --- Ascorbate, Magnesium --- Ascorbate, Sodium --- L Ascorbic Acid --- Magnesium di L Ascorbate --- di-L-Ascorbate, Magnesium --- antioxidants --- ascorbic acid --- infectious disease --- intravenous ascorbate

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Most complex respiratory conditions invoke interactions between genetic and environmental factors, such as smoking, pollution, and diet. There is increasing evidence that diet and nutrition are important factors, not only in disease prevention, but also in their contribution to the chronicity and heterogeneity of lung disorders. Nutrients exert potent effects on metabolism through a variety of regulatory mechanisms, resulting in local and systemic changes in metabolite levels. In this issue of Nutrients, we would like to bring together papers dealing with the topic of “Respiratory Diseases and Nutrition”. We welcome manuscripts detailing human and animal studies focused on the roles of dietary and metabolic factors in the initiation and progression of respiratory diseases, including, but not limited to, chronic obstructive pulmonary disease (COPD) and asthma. In vitro studies aimed at elucidating the potential molecular mechanisms of diet–metabolic interactions are also invited. We welcome different types of manuscript submissions, including original research articles and up-to-date reviews and commentaries.

Research & information: general --- Biology, life sciences --- Food & society --- antioxidant --- chronic obstructive pulmonary disease --- dietary pattern --- inflammation --- lung function --- Mediterranean diet --- nutrition --- oxidative stress --- polyphenol --- polyunsaturated fatty acid --- black ginseng --- oral administration --- influenza A virus --- cytokines --- antiviral --- lung development --- undernutrition --- lung diseases --- ghrelin --- leptin --- GLP-1 --- retinoids --- cholecalciferol --- fetal growth restriction --- respiratory distress syndrome --- lung transplantation --- body mass index --- body composition --- lean body mass --- muscle mass --- sarcopenia --- creatinine-height index --- obesity --- pregnancy --- allergic airway disease --- offspring --- high fat diet --- omega-3 index --- asthma --- fatty acids --- nutritional biomarkers --- pulmonary hypertension --- microbiota --- vitamin C --- vitamin D --- iron --- diet --- bisphenol A --- estrogen --- xenoestrogens --- para-inflammation --- endocrine --- alarmins --- allergy --- microbiome --- nutrients --- prematurity --- bronchopulmonary dysplasia --- weight loss --- children

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

Most complex respiratory conditions invoke interactions between genetic and environmental factors, such as smoking, pollution, and diet. There is increasing evidence that diet and nutrition are important factors, not only in disease prevention, but also in their contribution to the chronicity and heterogeneity of lung disorders. Nutrients exert potent effects on metabolism through a variety of regulatory mechanisms, resulting in local and systemic changes in metabolite levels. In this issue of Nutrients, we would like to bring together papers dealing with the topic of “Respiratory Diseases and Nutrition”. We welcome manuscripts detailing human and animal studies focused on the roles of dietary and metabolic factors in the initiation and progression of respiratory diseases, including, but not limited to, chronic obstructive pulmonary disease (COPD) and asthma. In vitro studies aimed at elucidating the potential molecular mechanisms of diet–metabolic interactions are also invited. We welcome different types of manuscript submissions, including original research articles and up-to-date reviews and commentaries.

Research & information: general --- Biology, life sciences --- Food & society --- antioxidant --- chronic obstructive pulmonary disease --- dietary pattern --- inflammation --- lung function --- Mediterranean diet --- nutrition --- oxidative stress --- polyphenol --- polyunsaturated fatty acid --- black ginseng --- oral administration --- influenza A virus --- cytokines --- antiviral --- lung development --- undernutrition --- lung diseases --- ghrelin --- leptin --- GLP-1 --- retinoids --- cholecalciferol --- fetal growth restriction --- respiratory distress syndrome --- lung transplantation --- body mass index --- body composition --- lean body mass --- muscle mass --- sarcopenia --- creatinine-height index --- obesity --- pregnancy --- allergic airway disease --- offspring --- high fat diet --- omega-3 index --- asthma --- fatty acids --- nutritional biomarkers --- pulmonary hypertension --- microbiota --- vitamin C --- vitamin D --- iron --- diet --- bisphenol A --- estrogen --- xenoestrogens --- para-inflammation --- endocrine --- alarmins --- allergy --- microbiome --- nutrients --- prematurity --- bronchopulmonary dysplasia --- weight loss --- children --- antioxidant --- chronic obstructive pulmonary disease --- dietary pattern --- inflammation --- lung function --- Mediterranean diet --- nutrition --- oxidative stress --- polyphenol --- polyunsaturated fatty acid --- black ginseng --- oral administration --- influenza A virus --- cytokines --- antiviral --- lung development --- undernutrition --- lung diseases --- ghrelin --- leptin --- GLP-1 --- retinoids --- cholecalciferol --- fetal growth restriction --- respiratory distress syndrome --- lung transplantation --- body mass index --- body composition --- lean body mass --- muscle mass --- sarcopenia --- creatinine-height index --- obesity --- pregnancy --- allergic airway disease --- offspring --- high fat diet --- omega-3 index --- asthma --- fatty acids --- nutritional biomarkers --- pulmonary hypertension --- microbiota --- vitamin C --- vitamin D --- iron --- diet --- bisphenol A --- estrogen --- xenoestrogens --- para-inflammation --- endocrine --- alarmins --- allergy --- microbiome --- nutrients --- prematurity --- bronchopulmonary dysplasia --- weight loss --- children

Choose an application

• Reference Manager
• EndNote
• RefWorks (Direct export to RefWorks)

The book starts with the editors’ preface summarizing the contributions of each of the following thirteen articles dealing with chemical and pharmacological aspects of the molecular modulators of the oxidative stress in regard to various therapeutic approaches in cardiovascular and neurodegenerative diseases, cancer, and diabetes. The seven articles present data from original research studies enlightening the roles and mechanisms of action of small molecular weight compounds (natural and synthetic; ascorbic acid/vitamin C, deferoxamine, N-acetylcysteine, MitoVitE, α-tocopherol, trolox, and ezetimibe) or proteins (SIRT3) in modulation of oxidative stress. In the six review papers, the authors present and discuss the possible therapeutic potential of novel approaches and compounds that are promising and deserve further investigation, in modulation of oxidative stress.

Research & information: general --- Biology, life sciences --- ascorbic acid --- deferoxamine --- N-acetylcysteine --- ischemia/reperfusion --- cardiac fibroblasts --- reactive oxygen species --- photobiomodulation --- reactive oxygen species (ROS) --- nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB) --- cancer --- diabetes --- wound healing --- glucose --- pentose phosphate pathway --- NADPH --- redox balance --- glycogen --- glycolysis --- stress resistance --- insulin resistance --- immunomodulation --- inflammation --- olive tree --- oxidative stress --- secoirioids --- sirtuin 3 --- high fat diet --- sex differences --- mice --- metabolic stress --- antioxidants --- ADHD --- Nrf2 --- NRF2-KEAP1 --- ROS --- cancer metabolism --- antioxidant --- cancer therapy --- chemoresistance --- radioresistance --- sepsis --- MitoVitE --- mitochondria --- gene expression --- cytokines --- mRNA --- vitamin C --- folic acid --- one-carbon metabolism --- C2C12 cells --- metabolomics --- mass spectrometry --- type 2 diabetes --- dipeptidyl peptidase-4 inhibitors --- biomarkers --- ER stress --- Ezetimibe --- ischemia-reperfusion --- ionizing radiation --- liver --- hydroperoxide --- epigenetics --- miR7/MAFG/Nrf2 axe --- ascorbic acid --- deferoxamine --- N-acetylcysteine --- ischemia/reperfusion --- cardiac fibroblasts --- reactive oxygen species --- photobiomodulation --- reactive oxygen species (ROS) --- nuclear factor kappa-light-chain-enhancer of activated B cells (NF-кB) --- cancer --- diabetes --- wound healing --- glucose --- pentose phosphate pathway --- NADPH --- redox balance --- glycogen --- glycolysis --- stress resistance --- insulin resistance --- immunomodulation --- inflammation --- olive tree --- oxidative stress --- secoirioids --- sirtuin 3 --- high fat diet --- sex differences --- mice --- metabolic stress --- antioxidants --- ADHD --- Nrf2 --- NRF2-KEAP1 --- ROS --- cancer metabolism --- antioxidant --- cancer therapy --- chemoresistance --- radioresistance --- sepsis --- MitoVitE --- mitochondria --- gene expression --- cytokines --- mRNA --- vitamin C --- folic acid --- one-carbon metabolism --- C2C12 cells --- metabolomics --- mass spectrometry --- type 2 diabetes --- dipeptidyl peptidase-4 inhibitors --- biomarkers --- ER stress --- Ezetimibe --- ischemia-reperfusion --- ionizing radiation --- liver --- hydroperoxide --- epigenetics --- miR7/MAFG/Nrf2 axe